Results for 'CRISPR Therapeutics' Create an alert

CRISPR Therapeutics says it’s ready to test a CRISPR-based therapy on people.
Last week, Crispr Therapeutics announced it has asked regulators in Europe for permission to trial a cure for the disease beta thalassemia
CRISPR Therapeutics' stock is tumbling after a report that edited genes might cause cancer.
BREAKING: CRISPR Therapeutics, which aims to use gene editing to treat disease, is planning a $90 million IPO:
FDA slaps a clinical hold on sickle cell IND filed by Vertex and CRISPR Therapeutics
$VRTX $CRSP -20%
Coming soon: #CRISPR’s clinical debut. Vertex Pharmaceuticals and CRISPR Therapeutics will begin the first human studies of a CRISPR therapy in the U.S. and Europe next year.
Total(1) => 0.14608287811279 f_f_QM(2) => 0.12052702903748 indS(2) => 0.025468111038208 indM(2) => 0.094887018203735 indM_1(2) => 0.01623010635376 indM_2(2) => 0.012204170227051 indM_4(2) => 0.014176845550537 indM_5(2) => 0.015822887420654 indM_6(2) => 0.010432720184326 indM_7(2) => 0.0096077919006348 indM_8(2) => 0.0067081451416016 f_f_pTL(2) => 0.0059189796447754 f_f_dT(17) => 0.0056114196777344